INGR
Ingredion Incorporated NYSE Listed Dec 11, 1997$107.41
After hrs
$109.52
+1.98%
Mkt Cap $6.8B
52w Low $100.71
16.3% of range
52w High $141.78
50d MA $112.61
200d MA $116.89
P/E (TTM)
9.7x
EV/EBITDA
6.4x
P/B
1.6x
Debt/Equity
0.4x
ROE
3.9%
P/FCF
13.9x
RSI (14)
—
ATR (14)
—
Beta
0.69
50d MA
$112.61
200d MA
$116.89
Avg Volume
676.4K
Ingredion Incorporated, together with its subsidiaries, produces and sells starches and sweeteners for various industries. It operates through four segments: North America; South America; Asia-Pacific; and Europe, Middle East and Africa. The company offers sweetener products comprising glucose syrups, high maltose syrups, high fructose corn syrups, caramel colors, dextrose, polyols, maltodextrins, and glucose syrup solids, as well as food-grade and industrial starches, biomaterials, and nutrition ingredients. It also provides edible corn oil; refined corn oil to packers of cooking oil and to producers of margarine, salad dressings, shortening, mayonnaise, and other foods; and corn gluten feed used as protein feed for chickens, pet food, and aquaculture, as well as fruit and vegetable products, such as concentrates, purees and essences, pulse proteins, and hydrocolloids systems and blends. The company's products are derived primarily from processing corn and other starch-based materials, such as tapioca, potato, and rice. It serves food, beverage, brewing, and animal nutrition industries. The company was formerly known as Corn Products International, Inc. and changed its name to Ingredion Incorporated in June 2012. Ingredion Incorporated was founded in 1906 and is headquartered in Westchester, Illinois.
5 Westbrook Corporate Center · Westchester, IL 60154 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | TNS | 2.44 | 2.34 | -4.1% | 107.13 | +0.5% | -0.7% | +0.2% | — | — | — | — |
| Feb 3, 2026 | TNS | 2.59 | 2.53 | -2.3% | 120.41 | +0.4% | -0.4% | -0.4% | -1.3% | -0.2% | -0.9% | — |
| Nov 4, 2025 | TNS | 2.73 | 2.75 | +0.7% | 107.40 | +0.1% | +0.3% | +0.3% | -0.9% | +1.0% | +0.0% | — |
| Aug 1, 2025 | TNS | 2.78 | 2.87 | +3.2% | 126.37 | +0.8% | +0.2% | +0.2% | -0.1% | -0.9% | -0.1% | — |
| May 6, 2025 | TNS | 2.44 | 2.97 | +21.7% | 138.44 | -0.1% | -2.0% | -2.0% | -0.9% | -0.9% | -0.9% | — |
| Feb 4, 2025 | TNS | 2.54 | 2.63 | +3.5% | 127.13 | -0.7% | -0.7% | -0.7% | +0.2% | +0.6% | +0.3% | — |
| Nov 5, 2024 | TNS | 2.58 | 3.05 | +18.2% | 154.86 | -0.2% | -2.8% | -2.8% | -3.1% | -2.1% | -3.3% | — |
| Aug 6, 2024 | TNS | 2.49 | 2.87 | +15.3% | 127.95 | +0.5% | -1.2% | -1.2% | -0.9% | +1.7% | +0.2% | — |
| May 8, 2024 | TNS | 2.06 | 2.08 | +1.0% | 118.45 | +0.4% | +1.3% | +1.3% | +1.5% | +2.5% | -0.3% | — |
| Feb 6, 2024 | TNS | 1.87 | 1.97 | +5.3% | 109.71 | +0.0% | +0.9% | +0.9% | -0.2% | -1.4% | -0.6% | — |
| Nov 7, 2023 | TNS | 1.95 | 2.33 | +19.5% | 101.83 | -0.1% | -1.8% | -1.8% | -0.4% | +0.5% | +0.4% | — |
| Aug 8, 2023 | TNS | 2.33 | 2.32 | -0.4% | 101.03 | +0.0% | +0.0% | +0.0% | -1.0% | -2.3% | -2.4% | — |
| May 3, 2023 | BMO | 2.01 | 2.80 | +39.3% | 109.95 | -0.3% | -1.3% | -1.3% | -1.4% | -1.4% | -1.4% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22 | Oppenheimer | Maintains | Outperform → Outperform | — | $113.20 | $113.26 | +0.1% | -0.5% | -0.3% | -0.5% | -0.2% | -0.2% |
| Apr 9 | UBS | Maintains | Neutral → Neutral | — | $113.56 | $112.94 | -0.5% | +1.2% | +1.0% | +0.0% | -0.5% | -0.8% |
| Feb 5 | UBS | Maintains | Neutral → Neutral | — | $119.96 | $119.28 | -0.6% | -0.9% | +0.1% | -0.6% | -1.0% | -0.1% |
| Feb 4 | Barclays | Maintains | Equal Weight → Equal Weight | — | $120.41 | $120.92 | +0.4% | -0.4% | -1.3% | -0.2% | -0.9% | -1.4% |
| Feb 4 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $120.41 | $120.92 | +0.4% | -0.4% | -1.3% | -0.2% | -0.9% | -1.4% |
| Nov 6 | Barclays | Downgrade | Overweight → Equal Weight | — | $107.70 | $105.75 | -1.8% | -1.2% | +0.7% | -0.3% | +1.5% | +0.4% |
| Nov 5 | UBS | Maintains | Neutral → Neutral | — | $107.40 | $107.49 | +0.1% | +0.3% | -0.9% | +1.0% | +0.0% | +1.8% |
| Nov 5 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $107.40 | $107.49 | +0.1% | +0.3% | -0.9% | +1.0% | +0.0% | +1.8% |
| Nov 5 | BMO Capital | Maintains | Market Perform → Market Perform | — | $107.40 | $107.49 | +0.1% | +0.3% | -0.9% | +1.0% | +0.0% | +1.8% |
| Oct 6 | UBS | Maintains | Neutral → Neutral | — | $120.87 | $120.23 | -0.5% | -0.5% | -0.2% | +0.6% | -1.1% | -0.9% |
| Jul 9 | UBS | Maintains | Neutral → Neutral | — | $136.73 | $137.56 | +0.6% | -0.5% | -0.3% | -0.7% | -0.5% | -1.7% |
| Apr 22 | Oppenheimer | Maintains | Outperform → Outperform | — | $128.41 | $128.91 | +0.4% | +1.8% | +1.4% | +1.3% | +1.4% | +2.1% |
| Apr 7 | UBS | Downgrade | Buy → Neutral | — | $130.89 | $127.88 | -2.3% | -4.3% | -5.9% | -2.1% | -2.6% | -0.7% |
| Feb 5 | BMO Capital | Maintains | Market Perform → Market Perform | — | $127.13 | $126.26 | -0.7% | -0.7% | +0.2% | +0.6% | +0.3% | +1.2% |
| Feb 5 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $127.13 | $126.26 | -0.7% | -0.7% | +0.2% | +0.6% | +0.3% | +1.2% |
| Feb 5 | Oppenheimer | Maintains | Outperform → Outperform | — | $127.13 | $126.26 | -0.7% | -0.7% | +0.2% | +0.6% | +0.3% | +1.2% |
| Nov 15 | UBS | Maintains | Buy → Buy | — | $149.19 | $148.73 | -0.3% | -5.6% | -6.9% | -4.8% | -4.6% | -3.2% |
| Nov 6 | Barclays | Maintains | Overweight → Overweight | — | $154.86 | $154.51 | -0.2% | -2.8% | -3.1% | -2.1% | -3.3% | -3.0% |
| Nov 6 | BMO Capital | Maintains | Market Perform → Market Perform | — | $154.86 | $154.51 | -0.2% | -2.8% | -3.1% | -2.1% | -3.3% | -3.0% |
| Nov 6 | Oppenheimer | Maintains | Outperform → Outperform | — | $154.86 | $154.51 | -0.2% | -2.8% | -3.1% | -2.1% | -3.3% | -3.0% |
| Oct 21 | Oppenheimer | Maintains | Outperform → Outperform | — | $134.26 | $134.35 | +0.1% | -0.2% | +0.1% | +1.3% | +1.0% | +0.6% |
| Aug 15 | UBS | Maintains | Buy → Buy | — | $130.88 | $131.52 | +0.5% | -0.1% | +0.1% | +1.1% | +0.8% | +1.2% |
| Aug 9 | Barclays | Upgrade | Equal Weight → Overweight | — | $126.76 | $128.40 | +1.3% | +2.7% | +1.2% | +2.4% | +3.3% | +3.2% |
| Aug 7 | BMO Capital | Maintains | Market Perform → Market Perform | — | $127.95 | $128.54 | +0.5% | -1.2% | -0.9% | +1.7% | +0.2% | +1.4% |
| Aug 7 | Oppenheimer | Maintains | Outperform → Outperform | — | $127.95 | $128.54 | +0.5% | -1.2% | -0.9% | +1.7% | +0.2% | +1.4% |
| May 9 | BMO Capital | Maintains | Market Perform → Market Perform | — | $118.45 | $118.98 | +0.4% | +1.3% | +1.5% | +2.5% | -0.3% | -0.7% |
| Mar 6 | Barclays | Maintains | Equal Weight → Equal Weight | — | $116.71 | $117.24 | +0.5% | -0.3% | -0.4% | +0.7% | +0.8% | +1.0% |
| Feb 16 | Goldman Sachs | Maintains | Buy → Buy | — | $114.91 | $114.79 | -0.1% | -0.6% | +0.8% | +0.3% | -0.2% | +0.1% |
| Feb 15 | Goldman Sachs | Upgrade | Neutral → Buy | — | $110.79 | $113.09 | +2.1% | +3.7% | +3.1% | +4.6% | +4.0% | +3.5% |
| Feb 7 | Stephens & Co. | Maintains | Overweight → Overweight | — | $109.71 | $109.75 | +0.0% | +0.9% | -0.2% | -1.4% | -0.6% | -1.2% |
| Nov 13 | UBS | Maintains | Buy → Buy | — | $102.39 | $102.50 | +0.1% | -0.1% | +0.8% | +1.1% | +0.4% | +0.8% |
| Nov 8 | Stephens & Co. | Maintains | Overweight → Overweight | — | $101.83 | $101.71 | -0.1% | -1.8% | -0.4% | +0.5% | +0.4% | +1.3% |
| Nov 1 | Barclays | Maintains | Equal Weight → Equal Weight | — | $93.58 | $93.22 | -0.4% | -0.5% | +1.4% | +2.5% | +2.2% | +8.8% |
| Aug 9 | BMO Capital | Maintains | Market Perform → Market Perform | — | $101.03 | $101.06 | +0.0% | +0.0% | -1.0% | -2.3% | -2.4% | -3.4% |
| Aug 9 | Stephens & Co. | Maintains | Overweight → Overweight | — | $101.03 | $101.06 | +0.0% | +0.0% | -1.0% | -2.3% | -2.4% | -3.4% |
| Jun 1 | Barclays | Maintains | Equal Weight → Equal Weight | — | $104.60 | $104.43 | -0.2% | +0.9% | +2.8% | +1.4% | +1.8% | +2.2% |
| May 4 | Barclays | Maintains | Equal Weight → Equal Weight | — | $109.95 | $109.67 | -0.3% | -1.3% | -1.4% | -1.4% | -1.4% | -0.0% |
| May 4 | BMO Capital | Maintains | Market Perform → Market Perform | — | $109.95 | $109.67 | -0.3% | -1.3% | -1.4% | -1.4% | -1.4% | -0.0% |
| May 4 | Stephens & Co. | Maintains | Overweight → Overweight | — | $109.95 | $109.67 | -0.3% | -1.3% | -1.4% | -1.4% | -1.4% | -0.0% |
| Apr 13 | UBS | Upgrade | Neutral → Buy | — | $101.56 | $103.74 | +2.1% | +4.6% | +3.5% | +3.2% | +3.4% | +3.9% |
| Mar 17 | Stephens & Co. | Maintains | Overweight → Overweight | — | $96.21 | $95.63 | -0.6% | +0.4% | +2.3% | +3.6% | +1.7% | +1.9% |
| Feb 9 | Credit Suisse | Maintains | Neutral → Neutral | — | $101.02 | $101.23 | +0.2% | -3.1% | -2.2% | -1.9% | -2.4% | -2.3% |
| Jan 23 | Barclays | Downgrade | Overweight → Equal Weight | — | $102.15 | $101.18 | -0.9% | -0.9% | -0.8% | +0.4% | +0.5% | -0.8% |
| Jan 17 | Stephens & Co. | Upgrade | Equal Weight → Overweight | — | $100.15 | $101.25 | +1.1% | +4.3% | +2.1% | +2.3% | +2.0% | +1.1% |
| Nov 7 | Credit Suisse | Maintains | Neutral → Neutral | — | $93.19 | $93.76 | +0.6% | -0.0% | -0.1% | -1.2% | +1.3% | -0.7% |
| Sep 30 | UBS | Maintains | Neutral → Neutral | — | $82.09 | $82.04 | -0.1% | -1.9% | -0.5% | +2.0% | -0.1% | -1.7% |
| Apr 12 | Credit Suisse | Downgrade | Outperform → Neutral | — | $90.12 | $88.73 | -1.5% | -2.8% | -1.8% | -0.7% | -1.2% | +0.2% |
| Nov 9 | Barclays | Maintains | Overweight → Overweight | — | $99.03 | $99.45 | +0.4% | +0.7% | +1.6% | +0.4% | +0.3% | +1.1% |
| Nov 3 | BMO Capital | Upgrade | Market Perform → Outperform | — | $92.51 | $96.96 | +4.8% | +3.7% | +4.2% | +6.2% | +7.0% | +7.8% |
| Nov 3 | Credit Suisse | Upgrade | Neutral → Outperform | — | $92.51 | $96.96 | +4.8% | +3.7% | +4.2% | +6.2% | +7.0% | +7.8% |
No insider trades available.
8-K
Ingredion Incorporated -- 8-K Filing
Ingredion Incorporated disclosed forward-looking statements in its 8-K filing while invoking safe harbor protections under securities laws to limit liability for future projections.
May 5
8-K · 2.02
!! High
Ingredion Incorporated -- 8-K 2.02: Earnings Results
Ingredion reported first-quarter 2026 earnings results, with the company disclosing its condensed consolidated financial performance for the period ended March 31, 2026.
May 5
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
INGR's appointment of an interim CFO signals potential financial leadership instability and suggests the company is searching for a permanent replacement, which could create near-term uncertainty for investors regarding financial strategy and decision-making.
Mar 25
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
A director compensation arrangement change suggests potential governance restructuring; investors should monitor whether this reflects leadership transition costs or strategic board composition shifts affecting future decision-making quality.
Mar 23
8-K · 8.01
!! High
Ingredion Incorporated -- 8-K 8.01: Material Event / Announcement
Ingredion's board consolidated leadership by naming CEO James P. Zallie as chairman, strengthening executive authority but potentially raising governance independence concerns for investors.
Feb 11
8-K
Ingredion Incorporated -- 8-K Filing
Ingredion's record full-year results were propelled by strong Texture Healthful Solutions and LATAM Food Industrial Ingredients performance, though U.S. Food Industrial Ingredients recovery lagged expectations.
Feb 3
Data updated apr 25, 2026 3:37pm
· Source: massive.com